Alia Therapeutics

Developer of gene therapies to cure rare genetic disorders

placeTrento, Trentino South Tyrol, Italy calendar_todayFounded 2018 groups10 employees language aliatherapeutics.com

Innovation

12 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 2,059 times.

YearFilings
20211
20221
20234
20245
20257
20261

Social engagement

Social engagement: 3.3K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Sofinnova Partners.

Investor typeCountShare
Venture capital2100%

Recent activity

13 Apr 2026
Recognition
1 Nov 2025
Event
EMBO Workshop on CRISPR
8 Oct 2025
Event
ESGCT25 conference
Coming soon